Abstract
C14H11F2N3S, monoclinic, C2/c (no. 15), a = 18.5399(19) Å, b = 9.5907(10) Å, c = 16.8149(17) Å, β = 111.307(2)°, V = 2785.5(5) Å3, Z = 8, Rgt(F) = 0.0390, wRref(F2) = 0.1317, T = 293(2) K.
The crystal structure is shown in the figure. Tables 1 and 2 contain details on crystal structure and measurement conditions and a list of the atoms including atomic coordinates and displacement parameters.
Crystal collection and handling.
Crystal: | Block, colorless |
Size: | 0.25 × 0.23 × 0.20 mm |
Wavelength: | Mo Kαradiation (λ = 0.71073 Å) |
μ: | 0.247 mm−1 |
Diffractometer, scan mode: | Bruker APEX-II CCD, Φ and ω-scans |
θmax, completeness: | 25.00°, 100% |
N(hkl)measured, N(hkl)unique, Rint: | 7800, 2458, 0.0242 |
Criterion for Iobs, N(hkl)gt: | Iobs > 2σ(Iobs), 2186 |
N(param)refined: | 181 |
Programs: | Bruker [1], SHELX [2] |
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).
Atom | x | y | z | Uiso*/Ueq |
---|---|---|---|---|
S1 | 0.40582(2) | 0.97556(5) | 1.12682(3) | 0.0512(2) |
F1 | 0.74160(9) | 0.39767(16) | 0.89571(11) | 0.0984(5) |
F2 | 0.20944(7) | 0.69860(18) | 0.68459(9) | 0.0920(5) |
N1 | 0.54461(8) | 0.86275(18) | 1.16615(10) | 0.0587(4) |
H1A | 0.5782 | 0.8150 | 1.1535 | 0.070 |
H1B | 0.5561 | 0.8955 | 1.2169 | 0.070 |
N2 | 0.46162(8) | 0.83120(16) | 1.02977(8) | 0.0457(4) |
H2A | 0.4175 | 0.8437 | 0.9894 | 0.055 |
N3 | 0.51857(7) | 0.75549(14) | 1.01526(8) | 0.0423(3) |
C1 | 0.56551(9) | 0.61877(15) | 0.92831(10) | 0.0377(4) |
C2 | 0.64247(9) | 0.65024(18) | 0.97601(11) | 0.0440(4) |
H2 | 0.6539 | 0.7230 | 1.0152 | 0.053 |
C3 | 0.70198(10) | 0.5754(2) | 0.96604(13) | 0.0539(5) |
H3 | 0.7533 | 0.5958 | 0.9985 | 0.065 |
C4 | 0.68358(12) | 0.4702(2) | 0.90702(14) | 0.0604(5) |
C5 | 0.60895(13) | 0.4351(2) | 0.85866(14) | 0.0625(5) |
H5 | 0.5985 | 0.3622 | 0.8197 | 0.075 |
C6 | 0.54932(11) | 0.51068(18) | 0.86910(12) | 0.0497(4) |
H6 | 0.4982 | 0.4891 | 0.8364 | 0.060 |
C7 | 0.42325(9) | 0.69630(15) | 0.87373(10) | 0.0364(4) |
C8 | 0.36178(11) | 0.6305(2) | 0.88556(12) | 0.0584(5) |
H8 | 0.3692 | 0.5859 | 0.9371 | 0.070 |
C9 | 0.28938(11) | 0.6299(2) | 0.82191(14) | 0.0657(6) |
H9 | 0.2479 | 0.5850 | 0.8296 | 0.079 |
C10 | 0.28025(10) | 0.6968(2) | 0.74770(12) | 0.0535(5) |
C11 | 0.33862(10) | 0.7645(2) | 0.73339(11) | 0.0526(4) |
H11 | 0.3302 | 0.8100 | 0.6819 | 0.063 |
C12 | 0.41110(9) | 0.76395(18) | 0.79759(10) | 0.0444(4) |
H12 | 0.4520 | 0.8097 | 0.7893 | 0.053 |
C13 | 0.50189(9) | 0.69505(15) | 0.94241(10) | 0.0374(4) |
C14 | 0.47545(9) | 0.88571(16) | 1.10779(10) | 0.0413(4) |
Source of material
The title compound was synthesized by the reaction of hydrazinecarbothioamide (1 mmol, 91.1 mg) with bis(4-fluorophenyl)methanone (1 mmol, 218.2 mg) in ethanol (15 mL) containing catalytic amounts of glacial acetic acid under reflux conditions (353 K) for 3 h. When cooled to room temperature, the solution was filtrated and then stand at room temperature. After about 3 days, colourless block crystals were obtained.
Experimental details
All H atoms were geometrically placed in calculated positions (C—H = 0.93 Å, N—H = 0.86 Å ) and refined as riding atoms, with Uiso = 1.2Ueq of the parent atoms.
Discussion
As one important kind of Schiff-bases, thiosemicarbazones constitute an important class of N, S donor ligands and have gained more and more attention in recent years not only because of their chemistry, but also their biological activities [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13], [14]. Compared with the traditional thiosemicarbazones, the fluorine-containing thiosemicarbazones may exhibit other biological activities because of the inclusion of fluorine atoms in the molecules often has a great influence on their physical and chemical properties. But the fluorine-containing thiosemicarbazones are not well studied [11], [15]. In order to search for new thiosemicarbazones containing fluorine atoms, the title compound was synthesized.
There is one title molecule in the asymmetric unit. The C13 = N3 bond distance in the molecule of 1.287(2) Å exhibits the expected value for a double-bond. The C14 = S1 bond distance in the molecule is 1.6768(16) Å, which is between the typical C—S single-bond (1.82 Å) and the typical C = S double-bond (1.56 Å), thus reflecting a partial double bond character. The C = N—N angle of 118.20(12)° (C13 = N3—N2) is smaller than the expected 120°. The dihedral angle formed by the two phenyl rings is 80.6°. In the crystal structure, a dimer structure is formed by the N—H⋯S hydrogen bonds. The adjacent dimers are further linked into infinite chains by weak C—H⋯S hydrogen bonds. In addition, very weak N—H⋯F hydrogen bonds link these chains into layers.
Acknowledgements
This work was financial supported by Changsha Environmental Protection College.
References
Bruker. APEX2, SAINT and SADABS. Bruker AXS Inc., Madison, WI, USA (2008).Suche in Google Scholar
Sheldrick, G. M.: A short history of SHELX. Acta Crystallogr. A64 (2008) 112–122.10.1107/S0108767307043930Suche in Google Scholar PubMed
Lobana, T. S.; Sharma, R.; Bawa, G.; Khanna, S.: Bonding and structure trends of thiosemicarbazone derivatives of metals-an overview. Coord. Chem. Rev. 253 (2009) 977–1055.10.1016/j.ccr.2008.07.004Suche in Google Scholar
Haribabu, J.; Subhashree, G. R.; Saranya, S.; Gomathi, K.; Karvembu, R.; Gayathri, D.: Isatin based thiosemicarbazone derivatives as potential bioactive agents: Anti-oxidant and molecular docking studies. J. Mol. Struct. 1110 (2016) 185–195.10.1016/j.molstruc.2016.01.044Suche in Google Scholar
Idemudia, O. G.; Sadimenko, A. P.; Hosten, E. C.: Crystal structure of 4-propyl-3-methyl-1-phenyl-2-pyrazolin-5-one thiosemicarbazone, C15H19N5OS. Z. Kristallogr. NCS 230 (2015) 81.10.1515/ncrs-2014-0242Suche in Google Scholar
Liu, C.: Crystal structure of (E)-2-(anthracen-9-ylmethylene) hydrazinecarbothioamide, C16H13N3S. Z. Kristallogr. NCS 233 (2018) 315–316.10.1515/ncrs-2017-0313Suche in Google Scholar
Netalkar, P. P.; Netalkar, S. P.; Revankar, V. K.: Transition metal complexes of thiosemicarbazone: synthesis, structures and invitro antimicrobial studies. Polyhedron 100 (2015) 215–222.10.1016/j.poly.2015.07.075Suche in Google Scholar
Kate, A. N.; Kumbhar, A. A.; Khan, A. A.; Joshi, P. V.; Puranik, V. G.: Monitoring cellular uptake and cytotoxicity of copper(II) complex using a fluorescent anthracene thiosemicarbazone ligand. Bioconjug. Chem. 25 (2014) 102–114.10.1021/bc400385dSuche in Google Scholar PubMed
Pelosi, G.: Thiosemicarbazone metal complexes: from structure to activity. Open Crystallogr. J. 3 (2010) 16–28.10.2174/1874846501003020016Suche in Google Scholar
Lovejoy, D. B.; Sharp, D. M.; Seebacher, N.; Obeidy, P.; Prichard, T.; Stefani, C.; Basha, M. T.; Sharpe, P. C.; Jansson, P. J.; Kalinowski, D. S.; Bernhardt, P. V.; Richardson, D. R.: Novel second-generation di-2-pyridylketone thiosemicarbazones show synergism with standard chemotherapeutics and demonstrate potent activity against lung cancer xenografts after oral and intravenous administration in vivo. J. Med. Chem. 55 (2012) 7230–7244.10.1021/jm300768uSuche in Google Scholar PubMed
Bautista, J. L.; Flores-Alamo, M.; Tiburcio, J.; Vieto, R.; Torrens, H.: Synthesis and structural characterization of fluorinated thiosemicarbazones. Molecules 18 (2013) 13111–13123.10.3390/molecules181013111Suche in Google Scholar PubMed PubMed Central
Pape, V. F. S.; Tóth, S.; Füredi, A.; Szebényi, K.; Lovrics, A.; Szabó, P.; Wiese, M.; Szakács, G.: Design, synthesis and biological evaluation of thiosemicarbazones, hydrazinobenzothiazoles and arylhydrazones as anticancer agents with a potential to overcome multidrug resistance. Eur. J. Med. Chem. 117 (2016) 335–354.10.1016/j.ejmech.2016.03.078Suche in Google Scholar PubMed
King, A. P.; Gellineau, H. A.; Ahn, J. E.; MacMillan, S. N.; Wilson, J. J.: Bis(thiosemicarbazone) complexes of Cobalt(III). Synthesis, characterization, and anticancer potential. Inorg. Chem. 56 (2017) 6609–6623.10.1021/acs.inorgchem.7b00710Suche in Google Scholar
Gatti, A.; Habtemariam, A.; Romero-Canelón, I.; Song, J. I.; Heer, B.; Clarkson, G. J.; Rogolino, M.; Sadler, P. J.; Carcelli, M.: Half-Sandwich Arene Ruthenium(II) and Osmium(II) Thiosemicarbazone complexes: solution behavior and antiproliferative activity. Organometallics 37 (2018) 891–899.10.1021/acs.organomet.7b00875Suche in Google Scholar PubMed PubMed Central
Kumar, G. D. K.; Chavarria, G. E.; Charlton-Sevcik, A. K.; Arispe, W. M.; MacDonough, M. T.; Strecker, T. E.; Chen, S. E.; Siim, B. G.; Chaplin, D. J.; Trawick, M. L.; Pinney, K. G.: Design, synthesis, and biological evaluation of potent thiosemicarbazone based cathepsin L inhibitors. Bioorg. Med. Chem. Lett. 20 (2010) 1415–1419.10.1016/j.bmcl.2009.12.090Suche in Google Scholar PubMed PubMed Central
©2018 Weiping Liu, published by De Gruyter, Berlin/Boston
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.
Artikel in diesem Heft
- Cover and Frontmatter
- Crystal structure of di-μ2-aqua-tetraaqua-bis(4-(1H-1,2,4-triazol-1-yl)benzoato-κN)disodium(I) C18H24N6Na2O10
- Crystal structure of diaqua-bis(2-bromo-4-chloro-6-formylphenolato-κ2O,O′)cobalt(II), C16H16Cl2CrN3O7
- Crystal structure of catena-poly[(μ2-1-(4-(1H-pyrazol-1-yl)phenyl)ethan-1-one-κ2N:O)-bis(1,1,1-trifluoro-4-oxo-4-(thiophen-2-yl)but-2-en-2-olato-κ2O,O′)copper(II)], C27H18CuF6N2O5S2
- Crystal structure of ethyl 2-amino-4-(3,5-difluorophenyl)-7-methyl-5-oxo-4H,5H-pyrano[4,3-b]pyran-3-carboxylate, C18H15F2NO5
- Crystal structure of 5,5′-dimethoxy-2,2′-[1,1′-(ethylenedioxydinitrilo)diethylidyne]diphenol, C20H24N2O6
- Crystal structure of (E)-1-(4-(((E)-3,5-dichloro-2-hydroxybenzylidene)amino)phenyl)ethan-1-one O-methyl oxime, C16H14Cl2N2O2
- Crystal structure of 2,3,9,10,16,17,23,24-octakis(2,6-dimethylphenoxy)phthalocyanine - trichloromethane (1/2), C98H84Cl6N8O8
- Crystal structure of methyl 2-((1-(2-(methoxycarbonyl)benzyl)-1H-1,2,3-triazol-4-yl)methoxy)-1-naphthoate, C24H21N3O5
- Crystal structure of catena-poly[(μ2-3,3′-thiodipropionato-κ2O:O′)-(bipyridine-κ2N,N′)copper(II)] C16H16CuN2O4S
- Crystal structure of [4-chloro-2-(((2-((3-ethoxy-2-oxidobenzylidene)amino)phenyl)imino)(phenyl)methyl)phenolato-κ4N,N′,O,O′}nickel(II) - ethyl acetate (1/1), C32H29ClN2NiO5
- Crystal structure of (4-(4-chlorophenyl)-5-ethyl-1,3-dioxane-5-carboxylato-κ2O,O′)-(5,5,7,12,12,14-hexamethyl-1,4,8,11-tetraazacyclotetradecane-κ4N,N′,N′′,N′′′)nickel(II) perchlorate monohydrate, C29H52Cl2N4NiO9
- Crystal structure of ethyl 2-amino-4-(3,4-dimethylphenyl)-7-methyl-5-oxo-4H,5H-pyrano[4,3-b]pyran-3-carboxylate, C20H21NO5
- Structure and photochromism of 1,2-bis[2-methyl-5-(3-quinolyl)-3-thienyl]-3,3,4,4,5,5-hexafluorocyclopent-1-ene, C33H20F6N2S2
- Crystal structure of catena-poly[diaqua-bis(μ2-3,5-di(1H-1,2,4-triazol-1-yl)benzoate-κ2N:N′)cobalt(II))] 2.5 hydrate, C22H23CoN12O8.50
- The crystal structure of dichlorido(1,3-dimesityl-1H-3λ4-imidazol-2-yl)(morpholine-κN)palladium(IV), C25H33Cl2N3OPd
- Crystal structure of catena-poly[bis(4,4′-dipyridylaminium-kN)-(μ2-germanowolframato-κ2O:O′)-(2,2′-bipyridine-κ2N,N′)copper(II)] with a Keggin-type heteropolyoxoanion, [Cu(C10H8N2)(C10H10N3)2][GeW12O40] ⋅ H2O
- Crystal structure of diaqua-(N-(1-(pyrazin-2-yl)ethylidene)pyridin-1-ium-4-carbohydrazonate-κ3N,N′,O)-tris[nitrato-κ2O,O′)lanthanum(III), C12H15N8O12La
- The crystal structure of 2-hydroxy-4-((2-hydroxy-4-methoxy-3,6-dimethylbenzoyl)oxy)-3,6-dimethylbenzoic acid–methanol (1/1), C20H24O8
- Crystal structure of guanidinium tetrapropylammonium bis(hydrogencarbonate) dihydrate, C15H40N4O8
- Crystal structure of (Z)-2-bromo-3-(3,5-di-tert-butyl-4-hydroxyphenyl)-1-phenylprop-2-en-1-one, C23H27BrO2
- Crystal structure of 2-(4-(4H-1,2,4-triazol-4-yl)phenyl)acetic acid, C10H9N3O4
- Crystal structure of 4,4′-(1,4-phenylene)bis(1H-imidazol-3-ium)bis(2-carboxybenzoate), C30H26N4O8
- Crystal structure of 4,4′-(4,10-diphenyl-4,10-dihydropyreno[4,5-d:9,10-d′]diimidazole-5,11-diyl)bis(N,N-diphenylaniline), C66H44N6
- Crystal structure of catena-poly[diaqua-bis(μ2-5-(3-(1H-imidazol-5-yl)phenyl)tetrazol-2-ido-κ2N:N′)cobalt(II)], C20H18CoN12O2
- Crystal structure of 1,3-dimethyl-2-(p-tolyl)-1H-perimidin-3-ium iodide 1.5 hydrate, C20H22IN2O1.5
- Crystal structure of 2-(4-methoxyphenyl)chromane, C16H16O2
- Crystal structure of poly[(μ2-2-carboxy-5-nitroisophthalato-κ2O:O′)-(μ2-4-((1H-imidazol-1-yl)methyl)pyridine-κ2N:N′)zinc(II)], C18H12N4O8Zn
- Crystal structure of bis(1-((2-ethyl-4-methyl-1H-imidazol-1-yl)methyl)-1H-benzo[d][1,2,3]triazole-κ2N:N′)tetraiodidodicadmium(II), [Cd2(C13H15N5)2I4]
- Crystal structure of tetramethylammonium bis(acetato-κ1O)-tetrakis(μ3-3-((hydroxyimino)methyl)-5-methoxy-2-oxidobenzoate-κ5O,O′:O′,N:O′′)tetrazinc(II) — N,N′-dimethylformamide — water (1/2/2), C62H96Zn4N10O28
- Crystal structure of poly[(μ4-5-tert-butylisophthalato-κ4O:O′:O′′:O′′′)-(1,3-dimethyl-2-imidazolidinone-κO)zinc(II)] C17H22N2O5Zn
- Crystal structure of [tris(2-benzimidazolylmethyl)amine-κ4N,N′,N′′,N′′′]-[(pyridine-2,6-dicarboxylato-κ2O,N)]cadmium(II)–methanol (1:3) C34H36CdN8O7
- The crystal structure of bis(1H-benzo[d]imidazol-2-amine-κN)-diiodidocadmium(II), C14H14CdI2N6
- Crystal structure of tetrakis(1H-benzimidazol-2-amine)-κN)-bis(μ2-sulfonato-κ2O:O′)dizinc(II) - methanol (1/1), C30H36N12O10S2Zn2
- Crystal structure of 3β-methoxy-20α-dimethylamino-pregn-5-ene, C24H41NO
- Crystal structure of dimethyl 4,4′-oxydibenzoate, C16H14O5
- Crystal structure of catena-poly[diiodido-(μ2-1,5-dimethyl-2-phenyl-4-((pyridin-3-ylmethylene)amino)-1,2-dihydro-3H-pyrazol-3-one-κ2N:O)zinc(II)], C17H16I2N4OZn
- Crystal structure of 4-((E)-((E)-5-(2-fluorobenzylidene)-1-((4-fluorophenyl)sulfonyl)-4-oxopiperidin-3-ylidene)methyl)benzonitrile, C26H18F2N2O3S
- Crystal structure of bis(acetato-κ1O)-bis(1-(pyridin-2-yl)ethan-1-one oxime-κ2N,N′)zinc(II), C18H22N4O6Zn
- The crystal structure of 9-butoxy-2-(hydroxymethyl)-2H-imidazo[1,5-a]quinolin-10-ium bromide, C17H21O2N2Br
- Crystal stucture of 2-(tert-butyl)-6-(hydroxymethyl)-4-methylphenol, C12H18O2
- Crystal structure of catena-poly[(2-(5-chloroquinolin-8-yloxy)-1-(pyrrolidin-1-yl)ethan-1-one-κ3N,O,O′)-(dinitrato-κ2O,O′)mercury(II)], C15H15N4O8ClHg
- Crystal structure of dimethyl (3aS,6R,6aS,7S)-1H,3H,6H,7H-3a,6:7,9a-diepoxybenzo[de]isochromene-3a1,6a-dicarboxylate, C16H16O7
- The crystal structure of 2-(dimethoxymethyl)-4-(4-methylphenyl)-1H-imidazole—petroleum ether-chloroform (3/1), C27H33Cl3N4O4
- Crystal structure of 8-(trifluoromethyl)imidazo[1,2-a]pyridine-3-carbaldehyde, C9H5F3N2O
- The crystal structure of N,N-diethyl-4,6-bis(naphthalen-2-yloxy)-1,3,5-triazin-2-amine, C27H24N4O2
- Crystal structure of 5-bromo-7-chloro-3,3a-dihydrocyclopenta[b]chromen-1(2H)-one, C12H8BrClO2
- Crystal structure of 2-(bis(4-fluorophenyl)methylene)hydrazine-1-carbothioamide, C14H11F2N3S
Artikel in diesem Heft
- Cover and Frontmatter
- Crystal structure of di-μ2-aqua-tetraaqua-bis(4-(1H-1,2,4-triazol-1-yl)benzoato-κN)disodium(I) C18H24N6Na2O10
- Crystal structure of diaqua-bis(2-bromo-4-chloro-6-formylphenolato-κ2O,O′)cobalt(II), C16H16Cl2CrN3O7
- Crystal structure of catena-poly[(μ2-1-(4-(1H-pyrazol-1-yl)phenyl)ethan-1-one-κ2N:O)-bis(1,1,1-trifluoro-4-oxo-4-(thiophen-2-yl)but-2-en-2-olato-κ2O,O′)copper(II)], C27H18CuF6N2O5S2
- Crystal structure of ethyl 2-amino-4-(3,5-difluorophenyl)-7-methyl-5-oxo-4H,5H-pyrano[4,3-b]pyran-3-carboxylate, C18H15F2NO5
- Crystal structure of 5,5′-dimethoxy-2,2′-[1,1′-(ethylenedioxydinitrilo)diethylidyne]diphenol, C20H24N2O6
- Crystal structure of (E)-1-(4-(((E)-3,5-dichloro-2-hydroxybenzylidene)amino)phenyl)ethan-1-one O-methyl oxime, C16H14Cl2N2O2
- Crystal structure of 2,3,9,10,16,17,23,24-octakis(2,6-dimethylphenoxy)phthalocyanine - trichloromethane (1/2), C98H84Cl6N8O8
- Crystal structure of methyl 2-((1-(2-(methoxycarbonyl)benzyl)-1H-1,2,3-triazol-4-yl)methoxy)-1-naphthoate, C24H21N3O5
- Crystal structure of catena-poly[(μ2-3,3′-thiodipropionato-κ2O:O′)-(bipyridine-κ2N,N′)copper(II)] C16H16CuN2O4S
- Crystal structure of [4-chloro-2-(((2-((3-ethoxy-2-oxidobenzylidene)amino)phenyl)imino)(phenyl)methyl)phenolato-κ4N,N′,O,O′}nickel(II) - ethyl acetate (1/1), C32H29ClN2NiO5
- Crystal structure of (4-(4-chlorophenyl)-5-ethyl-1,3-dioxane-5-carboxylato-κ2O,O′)-(5,5,7,12,12,14-hexamethyl-1,4,8,11-tetraazacyclotetradecane-κ4N,N′,N′′,N′′′)nickel(II) perchlorate monohydrate, C29H52Cl2N4NiO9
- Crystal structure of ethyl 2-amino-4-(3,4-dimethylphenyl)-7-methyl-5-oxo-4H,5H-pyrano[4,3-b]pyran-3-carboxylate, C20H21NO5
- Structure and photochromism of 1,2-bis[2-methyl-5-(3-quinolyl)-3-thienyl]-3,3,4,4,5,5-hexafluorocyclopent-1-ene, C33H20F6N2S2
- Crystal structure of catena-poly[diaqua-bis(μ2-3,5-di(1H-1,2,4-triazol-1-yl)benzoate-κ2N:N′)cobalt(II))] 2.5 hydrate, C22H23CoN12O8.50
- The crystal structure of dichlorido(1,3-dimesityl-1H-3λ4-imidazol-2-yl)(morpholine-κN)palladium(IV), C25H33Cl2N3OPd
- Crystal structure of catena-poly[bis(4,4′-dipyridylaminium-kN)-(μ2-germanowolframato-κ2O:O′)-(2,2′-bipyridine-κ2N,N′)copper(II)] with a Keggin-type heteropolyoxoanion, [Cu(C10H8N2)(C10H10N3)2][GeW12O40] ⋅ H2O
- Crystal structure of diaqua-(N-(1-(pyrazin-2-yl)ethylidene)pyridin-1-ium-4-carbohydrazonate-κ3N,N′,O)-tris[nitrato-κ2O,O′)lanthanum(III), C12H15N8O12La
- The crystal structure of 2-hydroxy-4-((2-hydroxy-4-methoxy-3,6-dimethylbenzoyl)oxy)-3,6-dimethylbenzoic acid–methanol (1/1), C20H24O8
- Crystal structure of guanidinium tetrapropylammonium bis(hydrogencarbonate) dihydrate, C15H40N4O8
- Crystal structure of (Z)-2-bromo-3-(3,5-di-tert-butyl-4-hydroxyphenyl)-1-phenylprop-2-en-1-one, C23H27BrO2
- Crystal structure of 2-(4-(4H-1,2,4-triazol-4-yl)phenyl)acetic acid, C10H9N3O4
- Crystal structure of 4,4′-(1,4-phenylene)bis(1H-imidazol-3-ium)bis(2-carboxybenzoate), C30H26N4O8
- Crystal structure of 4,4′-(4,10-diphenyl-4,10-dihydropyreno[4,5-d:9,10-d′]diimidazole-5,11-diyl)bis(N,N-diphenylaniline), C66H44N6
- Crystal structure of catena-poly[diaqua-bis(μ2-5-(3-(1H-imidazol-5-yl)phenyl)tetrazol-2-ido-κ2N:N′)cobalt(II)], C20H18CoN12O2
- Crystal structure of 1,3-dimethyl-2-(p-tolyl)-1H-perimidin-3-ium iodide 1.5 hydrate, C20H22IN2O1.5
- Crystal structure of 2-(4-methoxyphenyl)chromane, C16H16O2
- Crystal structure of poly[(μ2-2-carboxy-5-nitroisophthalato-κ2O:O′)-(μ2-4-((1H-imidazol-1-yl)methyl)pyridine-κ2N:N′)zinc(II)], C18H12N4O8Zn
- Crystal structure of bis(1-((2-ethyl-4-methyl-1H-imidazol-1-yl)methyl)-1H-benzo[d][1,2,3]triazole-κ2N:N′)tetraiodidodicadmium(II), [Cd2(C13H15N5)2I4]
- Crystal structure of tetramethylammonium bis(acetato-κ1O)-tetrakis(μ3-3-((hydroxyimino)methyl)-5-methoxy-2-oxidobenzoate-κ5O,O′:O′,N:O′′)tetrazinc(II) — N,N′-dimethylformamide — water (1/2/2), C62H96Zn4N10O28
- Crystal structure of poly[(μ4-5-tert-butylisophthalato-κ4O:O′:O′′:O′′′)-(1,3-dimethyl-2-imidazolidinone-κO)zinc(II)] C17H22N2O5Zn
- Crystal structure of [tris(2-benzimidazolylmethyl)amine-κ4N,N′,N′′,N′′′]-[(pyridine-2,6-dicarboxylato-κ2O,N)]cadmium(II)–methanol (1:3) C34H36CdN8O7
- The crystal structure of bis(1H-benzo[d]imidazol-2-amine-κN)-diiodidocadmium(II), C14H14CdI2N6
- Crystal structure of tetrakis(1H-benzimidazol-2-amine)-κN)-bis(μ2-sulfonato-κ2O:O′)dizinc(II) - methanol (1/1), C30H36N12O10S2Zn2
- Crystal structure of 3β-methoxy-20α-dimethylamino-pregn-5-ene, C24H41NO
- Crystal structure of dimethyl 4,4′-oxydibenzoate, C16H14O5
- Crystal structure of catena-poly[diiodido-(μ2-1,5-dimethyl-2-phenyl-4-((pyridin-3-ylmethylene)amino)-1,2-dihydro-3H-pyrazol-3-one-κ2N:O)zinc(II)], C17H16I2N4OZn
- Crystal structure of 4-((E)-((E)-5-(2-fluorobenzylidene)-1-((4-fluorophenyl)sulfonyl)-4-oxopiperidin-3-ylidene)methyl)benzonitrile, C26H18F2N2O3S
- Crystal structure of bis(acetato-κ1O)-bis(1-(pyridin-2-yl)ethan-1-one oxime-κ2N,N′)zinc(II), C18H22N4O6Zn
- The crystal structure of 9-butoxy-2-(hydroxymethyl)-2H-imidazo[1,5-a]quinolin-10-ium bromide, C17H21O2N2Br
- Crystal stucture of 2-(tert-butyl)-6-(hydroxymethyl)-4-methylphenol, C12H18O2
- Crystal structure of catena-poly[(2-(5-chloroquinolin-8-yloxy)-1-(pyrrolidin-1-yl)ethan-1-one-κ3N,O,O′)-(dinitrato-κ2O,O′)mercury(II)], C15H15N4O8ClHg
- Crystal structure of dimethyl (3aS,6R,6aS,7S)-1H,3H,6H,7H-3a,6:7,9a-diepoxybenzo[de]isochromene-3a1,6a-dicarboxylate, C16H16O7
- The crystal structure of 2-(dimethoxymethyl)-4-(4-methylphenyl)-1H-imidazole—petroleum ether-chloroform (3/1), C27H33Cl3N4O4
- Crystal structure of 8-(trifluoromethyl)imidazo[1,2-a]pyridine-3-carbaldehyde, C9H5F3N2O
- The crystal structure of N,N-diethyl-4,6-bis(naphthalen-2-yloxy)-1,3,5-triazin-2-amine, C27H24N4O2
- Crystal structure of 5-bromo-7-chloro-3,3a-dihydrocyclopenta[b]chromen-1(2H)-one, C12H8BrClO2
- Crystal structure of 2-(bis(4-fluorophenyl)methylene)hydrazine-1-carbothioamide, C14H11F2N3S